Oncology & Cancer

Repurposing a cancer drug to reduce COVID-19 lung inflammation

Winship Cancer Institute of Emory University (Winship) and Emory investigators are testing whether an anticancer drug can reduce lung inflammation in hospitalized COVID-19 patients, possibly preventing the need for intubation ...

Oncology & Cancer

Financial disclosure lacking in publication of clinical trials

A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...

Oncology & Cancer

Cutting off cervical cancer's fuel supply stymies tumors

Cancer therapies have improved—in some cases dramatically—over the past two decades, but treatment for cervical cancer has remained largely unchanged. All patients receive radiation and chemotherapy, yet despite the aggressive ...

Oncology & Cancer

Doctors' group offers ideas for easing cancer costs

(HealthDay)—New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money ...

Oncology & Cancer

Strategies compared for cancer medication submission lags

(HealthDay)—For development of oncology drugs in Japan, the global trial (GT) strategy and early-initiation bridging (BG) strategy are associated with shorter submission lag (SL) than late-initiation BG strategy, according ...

page 4 from 13